SCHEMBL8287565

SCHEMBL8287565

CCOC(=O)CNc1cc2c(cn1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.41
KDM4E B2RXH2 2/20 0.41
CSF1R P07333 1/20 0.41
ADORA1 P30542 2/20 0.38
ADORA3 P0DMS8 1/20 0.38
ELANE P08246 1/20 0.38
ALDH1A1 P00352 6/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
HPGD P15428 3/20 0.38
TP53 P04637 1/20 0.38
POLB P06746 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
MAPT P10636 2/20 0.37
RAB9A P51151 2/20 0.37
NPC1 O15118 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TSHR P16473 1/20 0.37
MAT2A P31153 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287514 0.87 EGFR (0.42) ADORA1ADORA3SMN1; SMN2MAPTRAB9A
SCHEMBL8287481 0.87 MAT2A (0.49) HTTKDM4ECSF1RADORA1ADORA3
SCHEMBL8287483 0.85 ADORA3 (0.45) KDM4EADORA1ADORA3ALDH1A1HPGD
SCHEMBL8287248 0.84 MEN1 (0.43) HTTKDM4ECSF1RALDH1A1SMN1; SMN2
SCHEMBL8287930 0.83 CSF1R (0.47) HTTKDM4ECSF1RADORA3ALDH1A1
SCHEMBL8285265 0.83 ALDH1A1 (0.46) CSF1RALDH1A1SMN1; SMN2HPGDTP53
SCHEMBL8286470 0.81 KCNH3 (0.40) KDM4EALDH1A1
SCHEMBL8362929 0.81 PIK3CA (0.44) ADORA1ADORA3HPGDMEN1KMT2A
SCHEMBL8362927 0.80 MAT2A (0.44) HTTKDM4EADORA1ADORA3ALDH1A1
SCHEMBL8287591 0.80 LMNA (0.42) HTTKDM4EALDH1A1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed